UnknownNot Applicable

Efficacy and Safety in Pacemaker and Defibrillator Implantation Via Cephalic Versus Axillary Vein Access (CEPHAX)

Spain240 participantsStarted 2017-10-01

Plain-language summary

This clinical trial evaluates the efficacy and safety of axillary versus cephalic venous access in the pacemakers and defibrillators implantation. Half of participants will receive the implant via fluoroscopy guided axillary venous access and the other half will receive the implant via improved cephalic venous access.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with a endovenous pacemaker or defibrillator indication. Exclusion Criteria: * Pre-existing ipsilateral pacing electrode. * Previous ipsilateral lymphadenectomy. * Indication of cardiac resynchronization therapy.

What they're measuring

Implant Success

Timeframe: 30 days

Implant Complications

Timeframe: 30 days

Trial details

NCT IDNCT03860090

SponsorCastilla-La Mancha Health Service

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-02-20

View on ClinicalTrials.gov More Pacemakers trials